The Life Science Equipment Market to Register a CAGR of 6.2% during the Forecast Period to Reach $92.21 Billion by 2030. Life science equipment refers to systems and instruments utilized for research, development, and analytical purposes in various industries, including pharmaceutical and biotechnology, proteomics, genomics, and diagnostics. It includes various equipment such as spectrometers, centrifuges, PCR machines, microscopes, DNA sequencers, and other specialized equipment used in life science laboratories.
Increasing pharmaceutical and biotech R&D expenditures, government initiatives supporting life sciences R&D, the increasing prevalence of chronic and infectious diseases, and growth in initiatives to control environmental pollution are the driving factors for the market. Moreover, growing demand for multi-analyte and multi-instrument controls is expected to create growth opportunities for the market.
Here are the top 10 companies operating in the Life Science Equipment Market
Founded in 2006 and headquartered in Massachusetts, U.S., Thermo Fisher offers products and services in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, government, and academic sectors. The company operates through four segments: Life Science Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The company operates in the life science equipment market through the Life Sciences Solutions, Analytical Instruments, and Laboratory Products, and Biopharma Services segments. These segments provide reagents, instruments, and consumables used in healthcare, biological and medical research, and clinical markets.
Thermo Fisher serves customers in pharmaceutical and biotech companies, hospitals, clinical diagnostic labs, universities, research & academic institutions, government firms, and environmental, industrial quality, and process control settings.
Danaher Corporation (U.S.)
Founded in 1969 and headquartered in Washington, D.C., U.S., Danaher designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company operates through four reportable business segments, namely, Biotechnology, Life Sciences, Diagnostics, and Environmental & Applied Solutions. The company operates in the life science equipment market through the Life Sciences and Diagnostics business segments.
The company has a presence in over 60 countries. Besides the U.S., the company has a significant presence in China, Denmark, Germany, Singapore, Sweden, Switzerland, and the U.K. Further, manufacturing facilities of the Diagnostics segment are located in North America, Europe, Asia, and Australia. Some of its subsidiaries operating in the life science equipment market include Cepheid AB (Sweden), Cepheid Europe SAS (France), Cepheid GmbH (Germany), Cepheid UK Ltd., Radiometer K.K (Japan), Radiometer Medical Equipment (Shanghai) Co. Ltd. (China), and HemoCue AB (Sweden)
Founded in 1999 and headquartered in California, U.S., Agilent Technologies, Inc. is engaged in testing and creating innovative technology. The company offers certain application-focused solutions such as software, consumables, services, and instruments for laboratory workflow. The company operates through three business segments, namely, Life Sciences and Applied Market, Diagnostics and Genomics, and Agilent CrossLab. The company provides life science equipment under the Life Sciences and Applied Markets and Diagnostics and Genomics business segments.
Agilent Technologies, Inc. sells its products primarily through direct sale channels and also through resellers, e-commerce platforms, distributors, and manufacturers’ representatives. The company has manufacturing sites and primary R&D in Washington, California, Delaware, Massachusetts, Texas, and other U.S. states. It also has facilities in Germany, Denmark, Australia, Japan, Italy, the U.K., and Singapore. Major subsidiaries of the company are Agilent LED International (California), Agilent Technologies World Trade, Inc. (Delaware), Objective Systems Integrators, S.A. de C.V. (Mexico), Agilent Technologies Australia Pty Ltd (Australia), Agilent Technologies Italia S.p.A. (Italy), Agilent Technologies Rhone SarL (Singapore), Yokogawa Analytical Systems, Inc. (Japan), and Agilent Technologies Deutschland Holding GmbH (Germany)
F. Hoffmann-La Roche (Switzerland)
Founded in 1896 and headquartered in Basel, Switzerland, Hoffmann-La Roche Ltd is a research-based healthcare company majorly engaged in creating innovative medicines and providing solutions for diagnostics. The company operates through two major business segments, namely, Pharmaceuticals and Diagnostics. The company operates life science equipment through the Diagnostics business segment. The Diagnostics segment is further categorized into Core Lab, Molecular Lab, Point of Care, Diabetes Care, and Pathology Lab. This segment manufactures equipment & reagents for research & medical diagnostic applications.
F. Hoffman-La Roche has 20 manufacturing sites and 27 research & development sites engaged in Pharmaceuticals and Diagnostics operations worldwide. Some of its subsidiaries across the globe are Roche Austria GmbH (Austria), Roche Diagnostics A/S (Denmark), Roche SAS (France), Roche Diagnostics GmbH (Germany), Roche Diagnostics Limited (Ireland), Roche Diagnostics S.p.A. (Italy), and F. Hoffmann-La Roche AG (Russia)
Founded in 1875 and headquartered in Kyoto, Japan, Shimadzu Corporation offers solutions for human health, safety and security of society, and industrial development. The company operates through four business segments, namely, Analytical and Measuring Instruments Business, Medical Systems Business, Industrial Machinery Business, and Aircraft Equipment Business.
The company operates through a global network and has offices in Brazil, Canada, Chile, China, Egypt, France, Germany, India, Italy, Japan, Mexico, Spain, Switzerland, the U.S., and Turkey. Furthermore, some of its subsidiaries are in Australia, Brazil, Canada, China, Denmark, France, Germany, Ireland, Italy, India, Japan, and the U.S. Shimadzu Scientific Instruments, Inc. (U.S.), Shimadzu Europa GmbH (Germany), Shimadzu Analytical India Pvt Ltd. (India), are some of the subsidiaries of the company.
Meticulous Research in its latest publication on Life Science Equipment Market has predicted the growth of 6.2% during the forecast year 2023-2030.
Waters Corporation (U.S.)
Founded in 1958 and headquartered in Massachusetts, U.S., Waters Corporation is a specialty measurement company that designs, manufactures, sells, and provides services for high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and comprehensive post-warranty service plans. The company also develops and supplies advanced software-based products that interface with its instruments.
Waters Corporation operates through two business segments, namely, Waters and TA. The Waters segment operates in the life science equipment market and is engaged in designing, manufacturing, selling, and servicing LC and MS instruments. The TA segment designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments.
The company has subsidiaries in Australia, Brazil, Canada, China, France, Germany, Hongkong, Ireland, and the Netherlands and operates its business through 19 U.S. facilities and 69 international facilities, including field offices.
Founded in 1960 and headquartered in Massachusetts, U.S., Bruker Corporation is a developer, manufacturer, and distributor of high-performance scientific instruments and analytical diagnostic solutions. Many of its products are used to detect, measure, and visualize structural characteristics of chemical, biological, and industrial material samples. The company has four operating segments, namely, Bruker BioSpin Group, Bruker CALID Group, Bruker Scientific Instruments (BSI) Nano Segment, and Bruker Energy & Supercon Technologies (BEST). It also has three reportable segments: BSI Life Science, BSI Nano, and BEST. The Bruker BioSpin and Bruker CALID Groups are aggregated into the BSI Life Science segment.
The company has direct sales throughout North America, China, Japan, and Europe through its distributors and sales representatives in Asia, Latin America, Africa, the Middle East, and Eastern Europe. The company has subsidiaries in Australia, Brazil, Canada, China, Delaware, France, Germany, India, Italy, Japan, Mexico, Netherlands, and Switzerland. Some of the names of the subsidiaries are Bruker Daltonik GmbH (Germany), Bruker BioSpin AG (Switzerland), Bruker Singapore Pte Ltd. (Singapore), and Bruker India PVT, Ltd. (India), among others.
Bio-Rad Laboratories, Inc. (U.S.)
Founded in 1952 and headquartered in California, U.S., Bio-Rad Laboratories, Inc. is a distributor and manufacturer of clinical diagnostics products and life science research. The company supplies and produces various systems and products for healthcare, analytical chemistry, and life sciences research. Bio-Rad Laboratories operates through two reportable segments, namely, Clinical Diagnostics and Life Sciences. The company operates in the life science equipment market through the life sciences business segments.
The company has a direct distribution source in over 35 countries outside the U.S., including Afghanistan, France, Hong Kong, Japan, Korea, Iceland, Germany, Australia, Spain, the Netherlands, and South Africa. Some of the major subsidiaries of the company include Bio-Rad Laboratories Pty. Limited (Australia), Bio-Rad Pacific Limited (U.S.), Bio-Rad Laboratories SAS (France), Bio-Rad Laboratories G.m.b.H. (Germany), Bio-Rad Laboratories K.K. (Japan), Bio-Rad Korea Limited (Korea), and Bio-Rad China Ltd. (Hong Kong).
Founded in 1897 and headquartered in New Jersey, U.S., Becton, Dickinson and Company (BD) is a medical technology company that manufactures and sells a wide range of medical devices, laboratory equipment, and diagnostic products used by healthcare institutions, clinical laboratories, pharmaceutical companies, and research centers. The company operates in three business segments, namely, BD Medical, BD Life Sciences, and BD Interventional, of which, through BD Life Sciences, the business company operates in the life science equipment market.
The BD Life Sciences business segment offers products through two major categories, namely, Integrated Diagnostic Solutions (Diagnostic Systems and Preanalytical Systems) and Biosciences. The Diagnostic Systems category offers numerous products with clinical and industrial applications. These products include molecular testing systems for infectious diseases & women’s health, liquid-based cytology systems for cervical cancer screening, culturing systems, rapid diagnostic assays for testing respiratory infections, microorganism identification, and drug susceptibility systems.
BD has a direct presence in the U.S., Brazil, Canada, China, France, Spain, the U.K., Germany, Hungary, India, Ireland, Israel, Italy, Japan, Mexico, Singapore, and the Netherlands through its manufacturing and sales operations. The R&D facilities of the company are located in China, France, India, Ireland, the U.S., and Singapore.
Illumina, Inc. (U.S.)
Founded in 1998 and headquartered in California, U.S., Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. The company offers integrated sequencing and microarray systems, consumables, and analysis tools used by genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company operates in the life science equipment market through the Core Illumina and GRAIL segments.
Illumina markets and distributes products across the U.S., Europe, Latin America, and Asia-Pacific. The company’s office, lab, and manufacturing facilities are located in the U.S., Singapore, and the U.K.. Some of its subsidiaries are BlueBee Holding BV (Netherlands), Conexio Genomics Pty Ltd. (Australia), Illumina Italy S.r.l., Illumina New Zealand Limited, Illumina (China) Scientific Co Ltd, Illumina Canada ULC, Illumina Singapore Pte. Ltd.
Authoritative Research on the Life Science Equipment Market – Global Opportunity Analysis and Industry Forecast (2023-2030)
Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.